AiM Medical Robotics, a leading developer of advanced robotic systems for MRI-guided neurosurgery, today announced a collaboration agreement with Siemens Healthineers for the implementation of an interface enabling AiM’s robotic platform to operate with MRI systems from Siemens Healthineers. The interface supports the integration of AiM’s compact, MRI-compatible robotic stereotactic neurosurgery system and associated workflow with the market-leading Siemens Healthineers’ MAG

Spectral AI has received De Novo Classification clearance from the U.S. Food and Drug Administration for its DeepView System, allowing the company to begin commercial distribution in the United States. The DeepView System is designed for use in burn care and can be used in burn centres, trauma centres and emergency departments. The platform uses artificial intelligence to support faster and more accurate treatment decisions in wound care. According to Spectral AI, the tech

InterSystems, a creative data technology provider powering more than one billion health records globally, today announced that its electronic health record (EHR) solutions have been certified as Class IIa Medical Devices under Regulation (MDR) certification under Regulation (EU) 2017/745. This approval marks the first fully unified AI-native EHR to achieve MDR Class IIa certification in the European Union. This certification demonstrates that InterSystems AI-native EHR meets stringe

Jupiter Endovascular, Inc. today announced that the SPIRARE II pivotal trial evaluating the use of the company’s Vertex™ Pulmonary Embolectomy System in patients with acute, intermediate-risk pulmonary embolism (PE) met both of its primary endpoints, demonstrating meaningful heart recovery and clinical safety. Late-breaking data from the trial were presented today by Catalin Toma, MD, Director of Interventional Cardiology at the UPMC Heart and Vascular Institute and the trial&rsqu

Autonomix Medical, Inc. a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,544,131 (the “131 patent”), titled “Systems, Methods, and Devices for Monitoring and Treatment of Tissues Within And/Or Through a Lumen Wall.” The newly issued patent strengthens the Company’s growing global intellectual property portfolio, which i

Amplitude Vascular Systems (AVS), a medical device company recently acquired by Stryker and focused on treating severely calcified arterial disease, today announced the enrollment of the first patient in its first-in-human (FIH) study for Pulsatile Intravascular Lithotripsy (PIVL) therapy in a coronary indication. The POWER CAD I study will evaluate the feasibility of the Pulse IVL™ System for the treatment of patients with moderate to severely calcified coronary arterial dise

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of the Viz Pulmonary™ Suite, an integrated AI-powered solution in the Viz.ai enterprise platform, designed to help health systems streamline care delivery for pulmonary conditions. The suite brings acute and chronic pulmonary workflows together in a single solution, giving clinicians a more streamlined way to manage patients to help get them on guideline-directed care.

Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in its Artis interventional imaging portfolio, which features the new Optiq AI imaging chain powered by artificial intelligence. The new interventional systems include the floor, biplane, ceiling, and pheno (or floor-mounted robotic) versions of the Artis vision platform; as well as the floor configurations of the Artis icono.explore and Artis genio platforms. The Optiq AI imaging chain commo

Veeva Systems (NYSE: VEEV) today announced that Smith+Nephew is unifying quality management with Veeva Quality Cloud. The global medical technology company is building a strategic foundation to drive its quality transformation. "As an integrated quality ecosystem, Veeva Quality Cloud will be central to maintaining our strong compliance profile with global health authorities," said Michelle Blevins, vice president, quality systems and regulatory compliance at Smith+Nephew.

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, announced the initiation of a pilot study evaluating its novel on-demand 12-lead ECG patch in patients with suspected coronary artery disease. The study is being conducted at two leading hospitals in Belgrade, Serbia. The initiation of the pilot study represents a significant step in the development of the HeartBeam patch which has the potential to disrupt